Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Asthma | 11 | 2021 | 4383 | 0.97 | Why? |
| Prostaglandin D2 | 1 | 2019 | 24 | 0.80 | Why? |
| Anti-Asthmatic Agents | 2 | 2019 | 427 | 0.65 | Why? |
| Rhinitis, Allergic | 4 | 2021 | 704 | 0.45 | Why? |
| TRPA1 Cation Channel | 2 | 2021 | 82 | 0.42 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.36 | Why? |
| Inflammation Mediators | 1 | 2019 | 2654 | 0.35 | Why? |
| NF-E2-Related Factor 2 | 2 | 2021 | 373 | 0.33 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 3832 | 0.33 | Why? |
| Adrenal Cortex Hormones | 3 | 2019 | 6537 | 0.31 | Why? |
| Spirometry | 2 | 2019 | 524 | 0.29 | Why? |
| Turkey | 9 | 2021 | 3937 | 0.26 | Why? |
| Respiratory Function Tests | 2 | 2019 | 1755 | 0.21 | Why? |
| Quality of Life | 2 | 2019 | 9820 | 0.21 | Why? |
| TRPV Cation Channels | 1 | 2021 | 88 | 0.20 | Why? |
| ADAM Proteins | 1 | 2019 | 43 | 0.20 | Why? |
| Spices | 1 | 2020 | 130 | 0.20 | Why? |
| Single Photon Emission Computed Tomography Computed Tomography | 1 | 2021 | 131 | 0.20 | Why? |
| Interleukin-5 | 1 | 2019 | 138 | 0.19 | Why? |
| Perfusion Imaging | 1 | 2021 | 199 | 0.19 | Why? |
| Bacteria, Anaerobic | 1 | 2018 | 20 | 0.19 | Why? |
| Dinoprostone | 1 | 2019 | 101 | 0.19 | Why? |
| Histamine H1 Antagonists | 1 | 2019 | 79 | 0.19 | Why? |
| Empyema, Pleural | 1 | 2018 | 46 | 0.18 | Why? |
| Omalizumab | 1 | 2018 | 158 | 0.15 | Why? |
| Common Cold | 1 | 2021 | 645 | 0.14 | Why? |
| Nomograms | 1 | 2021 | 790 | 0.14 | Why? |
| Physicians, Primary Care | 1 | 2017 | 298 | 0.13 | Why? |
| Anaphylaxis | 1 | 2021 | 940 | 0.11 | Why? |
| Education, Medical, Continuing | 1 | 2017 | 638 | 0.10 | Why? |
| Dysphonia | 1 | 2009 | 93 | 0.09 | Why? |
| Larynx | 1 | 2009 | 126 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Visual Analog Scale | 2 | 2019 | 151 | 0.09 | Why? |
| Diet | 1 | 2020 | 2052 | 0.09 | Why? |
| Hospitalization | 1 | 2019 | 54280 | 0.09 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Delivery of Health Care, Integrated | 1 | 2017 | 1549 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.07 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.07 | Why? |
| Laboratories | 1 | 2017 | 2858 | 0.07 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.07 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.07 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.06 | Why? |
| Mobile Applications | 1 | 2019 | 3032 | 0.06 | Why? |
| Adult | 10 | 2021 | 244371 | 0.06 | Why? |
| Male | 13 | 2021 | 367725 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.06 | Why? |
| Female | 12 | 2021 | 380317 | 0.06 | Why? |
| Brassica | 1 | 2021 | 66 | 0.05 | Why? |
| Antioxidants | 2 | 2021 | 1593 | 0.05 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.05 | Why? |
| Fermentation | 1 | 2020 | 156 | 0.05 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.05 | Why? |
| Epinephrine | 1 | 2021 | 323 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
| Humans | 20 | 2021 | 930598 | 0.05 | Why? |
| Disease Resistance | 1 | 2020 | 236 | 0.05 | Why? |
| Vegetables | 1 | 2020 | 340 | 0.04 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.04 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.04 | Why? |
| Probability | 1 | 2021 | 923 | 0.04 | Why? |
| Gram-Positive Bacteria | 1 | 2018 | 230 | 0.04 | Why? |
| Multimodal Imaging | 1 | 2021 | 534 | 0.04 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 121 | 0.04 | Why? |
| Efficiency | 1 | 2019 | 420 | 0.04 | Why? |
| Desensitization, Immunologic | 1 | 2021 | 574 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.04 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2021 | 665 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2020 | 1136 | 0.03 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.03 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.03 | Why? |
| Gram-Negative Bacteria | 1 | 2018 | 473 | 0.03 | Why? |
| Multimorbidity | 1 | 2018 | 703 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Pleural Effusion | 1 | 2018 | 680 | 0.03 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.03 | Why? |
| Stroboscopy | 1 | 2009 | 7 | 0.03 | Why? |
| Laryngeal Mucosa | 1 | 2009 | 11 | 0.03 | Why? |
| Laryngeal Muscles | 1 | 2009 | 11 | 0.03 | Why? |
| Vocal Cords | 1 | 2009 | 35 | 0.02 | Why? |
| Oxidative Stress | 1 | 2021 | 2050 | 0.02 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Hospitals, University | 1 | 2021 | 4173 | 0.02 | Why? |
| Electromyography | 1 | 2009 | 278 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Patient Compliance | 1 | 2017 | 1468 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Symptom Assessment | 1 | 2019 | 4967 | 0.02 | Why? |
| Laryngoscopy | 1 | 2009 | 413 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.02 | Why? |
| World Health Organization | 1 | 2017 | 4213 | 0.02 | Why? |
| Video Recording | 1 | 2009 | 786 | 0.02 | Why? |
| Administration, Inhalation | 1 | 2009 | 1647 | 0.02 | Why? |
| Aging | 1 | 2017 | 3581 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2017 | 8495 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.01 | Why? |
| Pandemics | 1 | 2021 | 389249 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
Gemicioglu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(123)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(385)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_